# 60Nd

> 60Nd is a Spanish biotech company and spin-off from Universidad Carlos III de Madrid (UC3M), pioneering mechanomedicine — the application of mechanobiology to biomedical research and drug development. Its flagship product, NeoMag, is a magneto-mechanical stimulation device that enables researchers to apply precise, non-invasive mechanical forces to living cells and tissues in real time.

60Nd, S.L. was founded to commercialize breakthrough technology in mechanobiology: the study of how mechanical forces affect living cells and tissues. The company holds an exclusive license from UC3M on the underlying technology and is currently transitioning from prototype to market-ready product, backed by a €2.4M EIC Transition grant from the European Union and private funding.

NeoMag allows biomedical researchers to simulate complex biological environments (tumor development, tissue recovery, cerebral cell response) by applying controlled magneto-mechanical stimuli to biological samples — cells, tissues, and organoids. It is compatible with conventional imaging and laboratory equipment and provides multidimensional, real-time mechanical control. Key applications include astrocyte stress response, spheroid and organoid migration, and disease modeling under controlled mechanical forces.

Target customers are research institutions, universities, and pharmaceutical companies worldwide. Notable users and collaborators include UCL, Institut Pasteur, UCSF, CNIC, and UC3M.

The company is based in Madrid, Spain, at the UC3M technology park. It was co-founded by Daniel García González, UC3M professor and winner of Spain's 2023 National Research Award for Young Researchers, Ricardo de la Torre González and Carlos Moya Ruiz.

## Company

- [Website](https://60nd.bio): Official 60Nd website with technology overview, use cases, and news
- [LinkedIn](https://www.linkedin.com/company/60nd): Company updates, hiring, and community engagement
- [Privacy Policy](https://60nd.bio/privacy-policy): Data protection and privacy information
- [Gender Equality Plan](https://60nd.bio/gender-equality-plan): Company diversity and inclusion commitments

## Technology

- [What Is NeoMag and Why Is It Different?](https://60nd.bio/magnetomechanics-explained-from-basics-to-breakthroughs/what-is-neomag-and-why-is-it-different): Overview of NeoMag's unique approach to magneto-mechanical stimulation
- [Why Mechanics Matter in Biology](https://60nd.bio/magnetomechanics-explained-from-basics-to-breakthroughs/why-mechanics-matter-in-biology): Introduction to mechanobiology and its relevance to biomedical research
- [The Science Behind Ultra-Soft MAPs: Why Stiffness Matters](https://60nd.bio/magnetomechanics-explained-from-basics-to-breakthroughs/the-science-behind-ultra-soft-maps-why-stiffness-matters): Technical deep dive into magneto-active polymers and material science

## Funding & Recognition

- [EIC Transition Grant](https://cordis.europa.eu): €2.4M European Innovation Council grant for commercialization (2025)
- [NEOTEC](https://www.cdti.es): Spanish national innovation grant from CDTI
- [ERC Proof of Concept — ISBIOMECH & MAGMATED](https://erc.europa.eu): European Research Council proof-of-concept projects underlying NeoMag technology

## Press & Media

- [El Mundo profile](https://elmundo.es): Feature on Daniel García González and 60Nd's vision
- [Cadena SER interview](https://cadenaser.com): Radio interview on mechanomedicine and NeoMag
- [Cordis article](https://cordis.europa.eu): "Novel method based on smart materials shows real-time cell damage"
- [Roche feature](https://roche.com): Article on magnetic silicone for wound healing applications

## Optional

- [Contact](https://60nd.bio/#footer): Get in touch with the 60Nd team